A high-purity research peptide studied in tissue-protection and inflammation research. Available in 10mg, with every batch independently tested and dispatched from the UK.
ARA-290 research peptide UK is Crown Peptides' synthetic erythropoietin-derived 11-amino-acid peptide, also known as cibinetide, available in 10mg strength for laboratory research.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
ARA-290, also known as cibinetide, is an 11-amino-acid synthetic peptide derived from a region of erythropoietin. It was designed to investigate tissue-protective signalling without reproducing erythropoietin's red-blood-cell-stimulating activity. Research interest centres on signalling through the heteromeric innate repair receptor and the cellular responses associated with that pathway.
ARA-290 has been investigated in models of inflammatory signalling, cellular stress and tissue response. A major research theme is the innate repair receptor, a receptor complex associated with tissue-protective signalling (Learn more). Experimental work has also examined peripheral nerve biology, small-fibre and microvascular models, cytokine responses and mechanisms involved in cellular recovery after stress or injury, alongside related peptide research such as [SS-31] and [MOTS-C].
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides ARA-290 is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification.
The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with ARA-290 may also be interested in [SS-31], [MOTS-C], [Epitalon], [NAD+] and [GHK-Cu] — other compounds studied in cellular stress, tissue-response and recovery-related research.
ARA-290 is an 11-amino-acid synthetic peptide derived from an erythropoietin sequence and is also known as cibinetide. Crown Peptides supplies it at 10mg strength.
Much of the mechanistic literature focuses on the innate repair receptor, a heteromeric receptor complex investigated in tissue-response and inflammatory-signalling models.
No. ARA-290 was designed specifically to retain interest in tissue-protective signalling while avoiding the erythropoietic activity associated with full-length erythropoietin.
Research includes inflammatory signalling, cellular stress, peripheral nerve biology, microvascular models and tissue-response pathways.
Peptide identity and purity can be assessed using analytical methods such as Mass Spectrometry and HPLC, with the batch-specific Certificate of Analysis providing the exact results.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.